Electrochemical Biosensors for Early Detection of Breast Cancer Publisher Pubmed

Summary: Electrochemical biosensors show promise for early breast cancer detection, offering affordable, non-invasive diagnostics. #BreastCancer #MedicalInnovation

Kiani P¹ ; Vatankhahan H² ; Zarehoseinabadi A³ ; Ferdosi F⁴ ; Ehtiati S⁵ ; Heidari P⁶ ; Dorostgou Z⁷ ; Movahedpour A⁸ ; Baktash A⁹ ; Rajabivahid M¹⁰ ; Khatami SH¹¹
Source: Clinica Chimica Acta Published:2025

Abstract

Breast cancer continues to be a significant contributor to global cancer deaths, particularly among women. This highlights the critical role of early detection and treatment in boosting survival rates. While conventional diagnostic methods like mammograms, biopsies, ultrasounds, and MRIs are valuable tools, limitations exist in terms of cost, invasiveness, and the requirement for specialized equipment and trained personnel. Recent shifts towards biosensor technologies offer a promising alternative for monitoring biological processes and providing accurate health diagnostics in a cost-effective, non-invasive manner. These biosensors are particularly advantageous for early detection of primary tumors, metastases, and recurrent diseases, contributing to more effective breast cancer management. The integration of biosensor technology into medical devices has led to the development of low-cost, adaptable, and efficient diagnostic tools. In this framework, electrochemical screening platforms have garnered significant attention due to their selectivity, affordability, and ease of result interpretation. The current review discusses various breast cancer biomarkers and the potential of electrochemical biosensors to revolutionize early cancer detection, making provision for new diagnostic platforms and personalized healthcare solutions. © 2024 Elsevier B.V.